The clinical impact of lifestyle interventions for the prevention of diabetes: an overview of systematic reviews
File(s)e013806.full.pdf (1.49 MB)
Published version
Author(s)
Howells, L
Musaddaq, B
McKay, AJ
Majeed, F
Type
Journal Article
Abstract
Objectives: To review the clinical outcomes of combined diet and physical activity interventions for populations at high risk of type 2 diabetes
Design: Overview of systematic reviews (search dates April-December 2015)
Setting: Any level of care; no geographical restriction
Participants: Adults at high risk of diabetes (as per measures of glycaemia, risk assessment, or presence of risk factors)
Interventions: Combined diet and physical activity interventions including ≥2 interactions with a healthcare professional, and ≥12 months follow-up
Outcome measures:
Primary: glycaemia, diabetes incidence
Secondary: behaviour change, measures of adiposity, vascular disease and mortality
Results: Nineteen recent reviews were identified for inclusion; five with AMSTAR scores <8. Most considered only randomised controlled trials (RCTs), and RCTs were the major data source in the remainder. Five trials were included in most reviews. Almost all analyses reported that interventions were associated with net reductions in diabetes incidence, measures of glycaemia and adiposity, at follow-up durations of up to 23 years (typically <6). Small effect sizes and potentially transient effect were reported in some studies, and some reviewers noted that durability of intervention impact was potentially sensitive to duration of intervention and adherence to behaviour change. Behaviour change, vascular disease and mortality outcome data were infrequently reported, and evidence of the impact of intervention on these outcomes was minimal. Evidence for age effect was mixed, and sex and ethnicity effect were little considered.
Conclusions: Relatively long-duration lifestyle interventions can limit or delay progression to diabetes under trial conditions. However, outcomes from more time-limited interventions, and those applied in routine clinical settings, appear more variable, in keeping with the findings of recent pragmatic trials. There is little evidence of intervention impact on vascular outcomes or mortality endpoints in any context. ‘Real-world’ implementation of lifestyle interventions for diabetes prevention may be expected to lead to modest outcomes.
Design: Overview of systematic reviews (search dates April-December 2015)
Setting: Any level of care; no geographical restriction
Participants: Adults at high risk of diabetes (as per measures of glycaemia, risk assessment, or presence of risk factors)
Interventions: Combined diet and physical activity interventions including ≥2 interactions with a healthcare professional, and ≥12 months follow-up
Outcome measures:
Primary: glycaemia, diabetes incidence
Secondary: behaviour change, measures of adiposity, vascular disease and mortality
Results: Nineteen recent reviews were identified for inclusion; five with AMSTAR scores <8. Most considered only randomised controlled trials (RCTs), and RCTs were the major data source in the remainder. Five trials were included in most reviews. Almost all analyses reported that interventions were associated with net reductions in diabetes incidence, measures of glycaemia and adiposity, at follow-up durations of up to 23 years (typically <6). Small effect sizes and potentially transient effect were reported in some studies, and some reviewers noted that durability of intervention impact was potentially sensitive to duration of intervention and adherence to behaviour change. Behaviour change, vascular disease and mortality outcome data were infrequently reported, and evidence of the impact of intervention on these outcomes was minimal. Evidence for age effect was mixed, and sex and ethnicity effect were little considered.
Conclusions: Relatively long-duration lifestyle interventions can limit or delay progression to diabetes under trial conditions. However, outcomes from more time-limited interventions, and those applied in routine clinical settings, appear more variable, in keeping with the findings of recent pragmatic trials. There is little evidence of intervention impact on vascular outcomes or mortality endpoints in any context. ‘Real-world’ implementation of lifestyle interventions for diabetes prevention may be expected to lead to modest outcomes.
Date Issued
2016-12-01
Date Acceptance
2016-10-25
Citation
BMJ Open, 2016, 6 (12)
ISSN
2044-6055
Publisher
BMJ Publishing Group
Journal / Book Title
BMJ Open
Volume
6
Issue
12
Copyright Statement
© 2016 The Authors, published by BMJ Publishing Group. This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
IMPAIRED GLUCOSE-TOLERANCE
RANDOMIZED CONTROLLED-TRIALS
SERVICES TASK-FORCE
SEARCH STRATEGIES
PHYSICAL-ACTIVITY
FOLLOW-UP
METAANALYSIS
RISK
PROGRAM
PEOPLE
Diabetes prevention programme
Diet
Intermediate hyperglycaemia
Physical activity
Publication Status
Published
Article Number
e013806